Phase 2 Cognitive Dysfunction trials recruiting now

All Cognitive Dysfunction trials, every phase

Phase 2 Cognitive Dysfunction trials

• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
  NCT07589595 · Phase: Phase 2 · Ages: 55 Years to 85 Years · Sex: All (male and female) · 72 locations
• ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults
  NCT07392723 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · 1 location
• Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
  NCT05565833 · Phase: Phase 2 · Ages: 65 Years and older · Sex: All (male and female) · 1 location
• Stem Cell Therapy for Early Alzheimer's Disease
  NCT06775964 · Phase: Phase 1, Phase 2 · Ages: 60 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.